The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmid shifting dynamics in the defense and technology services sector, Truist Securities has lowered its price target for Leidos Holdings (LDOS) from $195 to $160. Analysts expressed specific concerns regarding revenue prospects within the VBA, EIT, and software segments, despite the stock's notable decline since the beginning of the year. This adjustment follows recent downgrades from other major firms, including BofA Securities and Jefferies, who cited sustained pressure on the company's healthcare portfolio.
This downward revision arrives as industry peers face divergent trends; while recent earnings from Booz Allen Hamilton indicated robust growth in government contracting, Leidos is struggling with organic growth headwinds in its specialized tech units. Per market data, this performance gap highlights investor sensitivity toward profit margins in software-heavy contracts compared to traditional defense hardware.
Looking ahead, traders are focusing on the company's ability to stabilize its healthcare division as a primary catalyst for recovery. From a broader macro perspective, sentiment in the services sector may be influenced by the upcoming US ISM Services PMI data, scheduled for release on July 6, 2026, which will provide critical insights into input costs and employment trends for non-manufacturing firms.